Vimana
Vimana, the first startup out of the Duke-nference collaboration, is developing a multimodal generative AI platform to accelerate the development of precision diagnostics and therapies…
Neurophos
While GPUs have had massive success in accelerating AI workloads, digital approaches are typically limited by power consumption. On the other hand, proponents of optical…
EydisBio
Our mission is to leverage our unique platform technology and expertise to discover and develop novel small molecule therapies aimed at addressing serious unmet medical…
Piximune Therapeutics
Piximune Therapeutics is developing a novel class of antibodies designed to upregulate the innate neuroprotective mechanisms within the human retina to treat a broad range…
Actus Therapeutics
Actus Therapeutics, a privately held portfolio company of Asklepios BioPharmaceutical, Inc. (AskBio), was incorporated in 2017 to develop new therapies for rare diseases including Pompe…
Advanced Liquid Logic
Advanced Liquid Logic (ALL), a groundbreaking Research Triangle Park company built from Duke University research with North Carolina Biotechnology Center support, has been purchased for…
AegisCN
Novel solutions to enhance and restore neurological function Moving Ahead with Promising Brain Injury Therapy
Aerie Pharmaceuticals, Inc.
Developing new therapies for sight-threatening diseases of the eye. We are a publicly traded (NASDAQ: AERI), clinical-stage pharmaceutical company focused on the discovery, development…
AᴉRGUS
AᴉRGUS is an AI-based, low-cost, easy to use, and highly accurate solution. AᴉRGUS automatically inspects each camera and alerts you when the view is compromised by: Blur Tilt Tamper Obstruction Glare Black/blank screen More…